UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 4, 2026
Sale
Calculated transaction value
$2.18M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 3, 2026
Public filing date
Aug 4, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$516.31
Aug 3, 2026
Close before public filing
$516.31
Aug 3, 2026
Return since public filing
-3.72%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,218 shares @ $515.73
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000112
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$6.19M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 3, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 3, 2026 | $858.23K |
| United Therapeutics Corp UTHR Current | Sale | Aug 3, 2026 | $2.18M |
| United Therapeutics Corp UTHR | Sale | Aug 3, 2026 | $1.07M |
| United Therapeutics Corp UTHR | Sale | Aug 3, 2026 | $631.33K |
| United Therapeutics Corp UTHR | Sale | Aug 3, 2026 | $165.96K |
| United Therapeutics Corp UTHR | Exercise | Aug 3, 2026 | $0 |